Want to join the conversation?
$PFE 2Q15 PR: In vaccines, the company recently started a Phase 2b study for Staph aureus vaccine and depending upon the results this could serve as a registrational study. On July, Pfizer initiated a Phase 2 study to evaluate the safety, tolerability and immunogenicity of investigational C. difficile vaccine.
$TXMD flying high.. anyone here to catch..?
$CMG crashing. There seems to be nothing good to read about this company.
Impressed with $AMZN’s latest grocery ambitions. The new Amazon Go convenience store, is an absolute game changer.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$